Ignite Creation Date:
2024-05-06 @ 3:52 PM
Last Modification Date:
2024-10-26 @ 1:58 PM
Study NCT ID:
NCT04782960
Status:
UNKNOWN
Last Update Posted:
2021-03-04
First Post:
2021-02-16
Brief Title:
Subconjunctival Bupivacaine in Strabismus Surgery
Sponsor:
Fayoum University
Organization:
Fayoum University
Study Overview
Official Title:
The Effect of Subconjunctival Bupivacaine Injection in Squint Surgery for Postoperative Analgesia
Status:
UNKNOWN
Status Verified Date:
2021-03
Last Known Status:
NOT_YET_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study aimed to assess the effectiveness of the Subconjunctival bupivacaine on postoperative pain in Strabismus surgery under general anaesthesia
Detailed Description:
40 patients will schedule for elective Strabismus surgery under general anaesthesia and randomly allocated into two groups to receive Subconjunctival 05Bupivacaine groupB or Subconjunctival placebo 09 normal saline group at the end of the surgery and assess the postoperative pain at 0th30th 60th2nd h 4h6h12h24hand post operative nausea and vomiting
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None